Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources

por Ai, Xi, Fischer, Paul, Palyha, Oksana C, Wisniewski, Douglas, Hubbard, Brian, Akinsanya, Karen, Strack, Alison M, Ehrhardt, Anka G
Publicado 2012

PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES

por Olszewski, Adam, Kahn, David, Yoo, Brian, Nie, Zhe, Krilov, Goran, Tan, Joanne, Wright, Hamish, Weiss, Daniel, Yin, Wu, Akinsanya, Karen
Publicado 2023

Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey

por Jensen, Kristian K., Tadin-Strapps, Marija, Wang, Sheng-ping, Hubert, James, Kan, Yanqing, Ma, Yong, McLaren, David G., Previs, Stephen F., Herath, Kithsiri B., Mahsut, Ablatt, Liaw, Andy, Wang, Shubing, Stout, Steven J., Keohan, CarolAnn, Forrest, Gail, Coelho, David, Yendluri, Satya, Williams, Stephanie, Koser, Martin, Bartz, Steven, Akinsanya, Karen O., Pinto, Shirly
Publicado 2016